Wird geladen...
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Trabectedin (ET743, Yondelis(®), manufactured by Baxter Oncology GmbH, Halle/Westfalen, Germany, for Janssen Products, LP, Horsham, PA), derived from the marine ascidian, Ecteinascidia turbinata, is a natural alkaloid with multiple complex mechanisms of action. On 23 October 2015, 15 years after the...
Gespeichert in:
| Veröffentlicht in: | Adv Ther |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Healthcare
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939148/ https://ncbi.nlm.nih.gov/pubmed/27234989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0344-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|